You finally got some answers. Maybe a recent evaluation confirmed what you'd suspected for years. Maybe you're still circling the question, doing your own research at 11 p.m. the way you handle everything else.
Either way, a new question shows up fast: should you try medication?
Right behind it comes a flood of opinions. Friends with strong feelings. Headlines about shortages. That quiet voice wondering whether needing a pill says something about you.
Here's the thing. Medication is one tool, not the whole plan — and it's not a decision you have to make alone or all at once. Let's look at what it actually is.
How Common Is Adult ADHD — And How Many Adults Actually Treat It?
Adult ADHD is common: about 15.5 million U.S. adults — roughly 6% — have a current ADHD diagnosis, and more than half were diagnosed as adults (Staley et al., 2024). So if part of you feels like a fraud for even considering this — like ADHD is something other people have — you're in good company.
Read that again. Most adults with an ADHD diagnosis didn't get it as kids. They got it after years of wondering why smart, capable, and hardworking never quite added up to easy.
So if you're late to this, you're not behind. You're typical.
Here's what gets missed in the "everyone's on ADHD meds now" conversation: a lot of adults with ADHD aren't treated at all. That same CDC report found roughly 1 in 3 adults with ADHD aren't currently receiving treatment for it (Staley et al., 2024).
The story isn't that ADHD is wildly overtreated. For many adults, it's the opposite. The struggle is real, and help is often delayed.
That delay is part of why medication carries so much confusion. So let's clear it up — starting with what's actually on the table.
What Are the Main Types of ADHD Medication?
There are two main kinds of ADHD medication approved by the FDA: stimulants and non-stimulants. Both work on the same basic idea — helping certain brain chemicals do their job a little better.
How Do Stimulants Work?
Stimulants are the most common starting point for adults. They come in two families: amphetamine-based options (like Adderall and Vyvanse) and methylphenidate-based options (like Ritalin and Concerta).
They work by raising the levels of two brain chemicals: dopamine — which helps with motivation and reward — and norepinephrine — which helps with alertness and focus. Think of these as the chemicals that help your brain start a task and stick with it.
Most people feel stimulants working within 30 to 60 minutes. They also clear the body quickly, so the effect fades by the end of the day.
How Do Non-Stimulants Work?
Non-stimulants are the other option. These include atomoxetine (Strattera), viloxazine (Qelbree), and two medications called guanfacine and clonidine.
They mostly work on norepinephrine, and they build up slowly — taking about 2 to 6 weeks to reach full effect. That's slower than stimulants, but for some people it's the better fit.
Non-stimulants can be a good choice if stimulants cause too many side effects, if anxiety is part of the picture, or if there's a history of substance use to consider.
So how well do they work? A large review of 133 clinical trials found that stimulants — amphetamines in particular — were the most effective medications for reducing core ADHD symptoms in adults over the short term (Cortese et al., 2018). Non-stimulants helped too, with a generally smaller effect.
But "most effective on average" doesn't mean "best for you." That's an important point we'll come back to: finding the right medication is a process, not a guess that has to land on the first try.
Quick comparison:
- How fast they work: Stimulants kick in within an hour; non-stimulants take weeks.
- How long they last: Stimulants wear off the same day; non-stimulants work around the clock once they've built up.
- Who they tend to suit: Stimulants are first-line for most adults; non-stimulants often fit people with side-effect issues, co-occurring anxiety, or substance-use concerns.
- Using both: The two can sometimes be combined under a provider's guidance.
What Can You Realistically Expect From ADHD Medication?
Realistically, ADHD medication can meaningfully reduce core symptoms — distractibility, impulsivity, trouble getting started — but it doesn't teach skills or build habits on its own. So let's be honest about what it does and doesn't do.
At its best, it turns down the noise. It can make it easier to start the boring task, sit through the long meeting, or pause before the impulsive reply. For many adults, that's a real and welcome shift.
But medication doesn't teach you skills. It won't build your habits, organize your calendar, or decide what matters most this week. It opens a window — what you do with that window is up to you and the systems around you.
A major review in The Lancet Psychiatry found that while stimulants and atomoxetine reliably reduce core symptoms in the short term, there's no clear evidence they improve overall quality of life (Ostinelli et al., 2025).
In plain terms: medication can help you function with less friction. On its own, it's less likely to make you feel like your whole life suddenly clicked into place.
There's also the fear of feeling like a different person. This one's worth addressing head-on.
Properly dosed medication shouldn't flatten you out. If you feel dull, robotic, or "not yourself" — what some people describe as a zombie feeling — that's usually a sign the dose is too high or the medication isn't the right fit. Both are fixable.
The goal isn't to become someone new. It's to feel like yourself, with less static in the way.
Why Is Medication Only One Part of the Plan?
Medication works best as one part of a broader plan — combined with therapy, coaching, and lifestyle structure, rather than on its own. If medication opens a window, something has to happen while it's open. That's where the rest of the plan comes in.
The strongest results don't come from medication alone. They come from pairing it with skills-based support — things like therapy, coaching, and changes to how your days are built.
In a randomized trial of adults who still had symptoms despite medication, those who added cognitive behavioral therapy — a structured, skills-focused kind of therapy often shortened to CBT — improved more than those who received a comparison support program, and the gains held up a year later (Safren et al., 2010).
Medication also works best on a solid foundation. Sleep, movement, and outside structure — calendars, reminders, steady routines — all help your brain make the most of treatment.
None of this means medication is a crutch or a last resort. It means it's a tool that works better in good company.
This is also why an evaluation shouldn't end at a prescription. A thorough process looks at the whole picture — your history, your goals, the systems you're already using — and builds practical next steps from there.
That mix of clear answers and real-world follow-through is the point. Whether or not medication becomes part of your plan, you come away understanding how your brain works and what to do about it.
What Does the Medication Evaluation Process Look Like?
A thorough ADHD evaluation has several parts: a clinical interview, a history of how you function across different areas of life, standardized rating scales, and — if medication is chosen — a gradual dose-finding process. So if you're worried about being handed a prescription after a ten-minute chat, a real evaluation looks nothing like that.
There's no single test for ADHD — no blood draw, no brain scan, no one quiz that settles it. A proper diagnosis comes from a clinical interview, a look at your history across different parts of your life, and standardized rating scales like the Adult ADHD Self-Report Scale (ASRS) (Kessler et al., 2005).
The point isn't to label you. It's to understand the patterns — and to rule out other things, like anxiety, sleep problems, or thyroid issues, that can look a lot like ADHD.
If medication does become part of the plan, the next step is called titration — a technical word for a simple idea. You start at a low dose and adjust slowly, finding the smallest amount that helps with the fewest side effects.
Because stimulants act fast and leave the body quickly, that fine-tuning can often happen over days to a couple of weeks. Non-stimulants take longer, since they need weeks to build up.
Here's something that surprises a lot of people: there's no way to predict which medication will work best for you ahead of time. If the first one doesn't help, switching to another is normal — and it doesn't mean medication "failed" or that something's wrong with you.
Along the way, your provider keeps an eye on a few things: appetite, sleep, and heart rate or blood pressure. Most side effects show up early and ease as the dose settles.
It's also common for treatment to shift over time. One large 2024 study found that within a year of starting, about 48% of adults were still taking their medication, with lower numbers among young adults (Brikell et al., 2024).
That doesn't mean medication doesn't work. Sometimes people stop because they feel better. Sometimes the dose was never quite right, or life got in the way. It's a reason to keep the conversation with your provider going — not a one-time decision.
Can You Get ADHD Medication Through Telehealth in Tennessee?
Short answer: in most cases, yes — though a few rules shape how it works.
ADHD stimulants are Schedule II controlled substances, the most tightly regulated prescription category. In practice, that means no automatic refills — you'll usually get a new prescription each month — and closer oversight than with everyday medications.
For virtual care, the big question has been whether a provider can prescribe these medications over video. As of early 2026, federal rules allow it: telehealth flexibilities first introduced during the pandemic have been extended through December 31, 2026, letting qualified providers prescribe stimulants by video without requiring a prior in-person visit (DEA & HHS, 2025).
Tennessee law also allows a provider-patient relationship to be set up through telehealth (Tenn. Code Ann. § 63-1-155). The catch — and it's a fair one — is that an appropriate evaluation is still required. No one can responsibly prescribe a controlled medication based on a quick questionnaire alone.
Is There Still an ADHD Medication Shortage?
You've probably heard about it — and yes, it's still around.
The FDA first posted a shortage of immediate-release Adderall in October 2022, and supply has stayed inconsistent into 2026, especially for certain doses (U.S. FDA, 2022). It's been one of the more frustrating parts of getting and staying on treatment.
The numbers show how widespread it's been. During the shortage, 71.5% of adults taking stimulant medication reported trouble filling their prescriptions because the medication wasn't available (Staley et al., 2024).
So what helps? A few practical moves:
- Ask your provider about backup options, including different formulations or non-stimulant alternatives.
- Stick with one consistent pharmacy that knows your history.
- Ask whether a generic version is available and right for you.
None of this makes the shortage disappear. But it can make a real difference in how smoothly your treatment runs.
What Are the Most Common Myths About ADHD Medication?
A lot of the worry around ADHD medication comes from ideas that sound true but don't hold up. Let's clear up the big ones.
Myth: "ADHD medication is just legal speed."
Prescription stimulants and street drugs may share a chemical family, but dose and delivery change everything. Taken by mouth at a therapeutic dose, the medication raises brain chemicals slowly and steadily — not the rapid spike that creates a high. Some options, like Vyvanse, are built to release gradually for exactly that reason.
Myth: "Stimulants are addictive and will lead to addiction."
Used as prescribed and monitored by a provider, stimulants don't cause addiction. A large study of nearly 3 million patients found that ADHD medication didn't raise the risk of later substance problems — and may even lower it (Quinn et al., 2017). The risk rises with misuse, which is exactly what supervision is there to prevent.
Myth: "If medication helps you focus, that proves you have ADHD."
Not quite. Stimulants improve focus in almost everyone, ADHD or not — so a good response isn't a diagnosis, and a poor one doesn't rule it out. That's why diagnosis rests on a full clinical picture, not a trial run.
Myth: "Once you start, you're on it forever."
ADHD is often lifelong, but medication is a choice you can revisit. Stimulants don't build up in your system, so stopping simply ends the effect — which means you and your provider can adjust, pause, or rethink as life changes.
Myth: "Natural approaches are always better than medication."
Sleep, exercise, and structure genuinely help, and they're worth taking seriously. But for moderate-to-severe ADHD, they don't match medication's effect on core symptoms. The strongest results usually come from combining them — not picking a side.
Myth: "ADHD meds are overprescribed, and everyone's just faking it."
For adults, the bigger problem is the opposite. Roughly 1 in 3 adults with ADHD get no treatment at all (Staley et al., 2024). Careful evaluation is what protects against both over- and under-treatment — which is the whole reason to see a qualified provider instead of self-diagnosing online.
Frequently Asked Questions
Do I have to take ADHD medication if I'm diagnosed?
No. Medication is one option, not a requirement. Many adults combine it with coaching, therapy, and new routines — and some choose non-medication approaches entirely. The right plan is the one you build with your provider.
How long does ADHD medication take to work?
It depends on the type. Stimulants usually take effect within 30 to 60 minutes, while non-stimulants build up over about 2 to 6 weeks. Finding the right dose can take a little longer as you and your provider fine-tune it.
What's the difference between Adderall and Vyvanse?
Both are amphetamine-based stimulants, but Vyvanse (lisdexamfetamine) is a prodrug — inactive until your body converts it — so it releases more gradually and lasts longer, while Adderall acts faster and for a shorter time. Which one fits better depends on your symptoms and daily rhythm.
Can I get ADHD medication through telehealth in Tennessee?
In most cases, yes. As of early 2026, federal rules allow providers to prescribe ADHD stimulants by video without a prior in-person visit, and Tennessee permits telehealth care with an appropriate evaluation. A quick questionnaire alone isn't enough — a real assessment is still required.
Are ADHD stimulants addictive?
When taken as prescribed and monitored by a provider, no. Research on millions of patients has found that proper treatment doesn't increase the risk of addiction and may reduce it (Quinn et al., 2017). Misuse is a different matter, which is why oversight matters.
When You're Ready, We're Here
If you've been weighing whether medication fits your life, you don't have to sort it out alone. A professional evaluation can give you real answers — and a plan built around how your brain actually works.
MindCare Health offers virtual ADHD evaluations for adults across Tennessee. Appointments are private-pay, HSA/FSA eligible, and designed to fit a demanding schedule.
Whether or not medication becomes part of your plan, you'll come away with clarity and practical next steps.
Schedule your evaluation at evaluation.
This content is for educational purposes only. It is not intended to diagnose, treat, or replace professional medical advice. If you are experiencing mental health symptoms, please consult a licensed provider. Do not stop or adjust medication without medical supervision.
References
Brikell, I., Yao, H., Li, L., Astrup, A., Gao, L., Gillies, M. B., Xie, T., Zhang-James, Y., Dalsgaard, S., Engeland, A., Faraone, S. V., Haavik, J., Hartman, C., Ip, P., Jakobsdóttir Smári, U., Larsson, H., Man, K. K., de Oliveira Costa, J., Pearson, S.-A., … Chang, Z. (2024). ADHD medication discontinuation and persistence across the lifespan: A retrospective observational study using population-based databases. The Lancet Psychiatry, 11(1), 16–26. https://doi.org/10.1016/S2215-0366(23)00332-2
Cortese, S., Adamo, N., Del Giovane, C., Mohr-Jensen, C., Hayes, A. J., Carucci, S., Atkinson, L. Z., Tessari, L., Banaschewski, T., Coghill, D., Hollis, C., Simonoff, E., Zuddas, A., Barbui, C., Purgato, M., Steinhausen, H.-C., Shokraneh, F., Xia, J., & Cipriani, A. (2018). Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: A systematic review and network meta-analysis. The Lancet Psychiatry, 5(9), 727–738. https://doi.org/10.1016/S2215-0366(18)30269-4
Kessler, R. C., Adler, L., Ames, M., Demler, O., Faraone, S., Hiripi, E., Howes, M. J., Jin, R., Secnik, K., Spencer, T., Ustun, T. B., & Walters, E. E. (2005). The World Health Organization Adult ADHD Self-Report Scale (ASRS): A short screening scale for use in the general population. Psychological Medicine, 35(2), 245–256. https://doi.org/10.1017/S0033291704002892
Ostinelli, E. G., Schulze, M., Zangani, C., [complete remaining authors from article], … Cipriani, A. (2025). Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: A systematic review and component network meta-analysis. The Lancet Psychiatry, 12(1), 32–43. https://doi.org/10.1016/S2215-0366(24)00360-2
Quinn, P. D., Chang, Z., Hur, K., Gibbons, R. D., Lahey, B. B., Rickert, M. E., Sjölander, A., Lichtenstein, P., Larsson, H., & D'Onofrio, B. M. (2017). ADHD medication and substance-related problems. American Journal of Psychiatry, 174(9), 877–885. https://doi.org/10.1176/appi.ajp.2017.16060686
Safren, S. A., Sprich, S., Mimiaga, M. J., Surman, C., Knouse, L., Groves, M., & Otto, M. W. (2010). Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: A randomized controlled trial. JAMA, 304(8), 875–880. https://doi.org/10.1001/jama.2010.1192
Staley, B. S., Robinson, L. R., Claussen, A. H., Katz, S. M., Danielson, M. L., Summers, A. D., Farr, S. L., Blumberg, S. J., & Tinker, S. C. (2024). Attention-deficit/hyperactivity disorder diagnosis, treatment, and telehealth use in adults — National Center for Health Statistics Rapid Surveys System, United States, October–November 2023. MMWR. Morbidity and Mortality Weekly Report, 73(40), 890–895. https://doi.org/10.15585/mmwr.mm7340a1
Drug Enforcement Administration & Department of Health and Human Services. (2025, December 31). Fourth temporary extension of COVID-19 telemedicine flexibilities for prescription of controlled medications. Federal Register. https://www.federalregister.gov/documents/2025/12/31/2025-24123/
U.S. Food and Drug Administration. (2022, October 12). FDA announces shortage of Adderall. https://www.fda.gov/drugs/drug-safety-communications/fda-announces-shortage-adderall
Tenn. Code Ann. § 63-1-155 (2024); Tenn. Comp. R. & Regs. 0880-02-.14(7).